Acadia Healthcare
ACHC
254 hedge funds and large institutions have $1.73B invested in Acadia Healthcare in 2025 Q4 according to their latest regulatory filings, with 60 funds opening new positions, 82 increasing their positions, 88 reducing their positions, and 72 closing their positions.
65% more call options, than puts
Call options by funds: $16.6M | Put options by funds: $10M
8.88% more ownership
Funds ownership: 122.97% → 131.85% (+8.9%)
7% less repeat investments, than reductions
Existing positions increased: 82 | Existing positions reduced: 88
6% less funds holding
Funds holding: 270 → 254 (-16)
17% less first-time investments, than exits
New positions opened: 60 | Existing positions closed: 72
39% less capital invested
Capital invested by funds: $2.81B → $1.73B (-$1.09B)
60% less funds holding in top 10
Funds holding in top 10: 10 → 4 (-6)
Top Buyers
| 1 |
Goldman Sachs
New York
|
+$72.2M |
| 2 |
JFG
Jefferies Financial Group
New York
|
+$63.9M |
| 3 |
DM
Deerfield Management
New York
|
+$63M |
| 4 |
DCM
DME Capital Management
New York
|
+$46.9M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$44.5M |
Top Sellers
| 1 |
SHCM
Sachem Head Capital Management
New York
|
-$104M |
| 2 |
PCP
P2 Capital Partners
New York
|
-$57.9M |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$44.6M |
| 4 |
ECM
Engine Capital Management
New York
|
-$42.7M |
| 5 |
MC
Maverick Capital
Dallas,
Texas
|
-$39.8M |
ACHC Hedge Fund Activity: Q4 2025 in Review
254 of the 8,223 institutional investors tracked by Wall St. Rank reported a position in Acadia Healthcare (ACHC) for Q4 2025, worth a combined $1.73B — down 39% from $2.81B a quarter earlier.
Sellers outnumbered buyers: 72 funds closed out of ACHC and 60 opened new positions — a net loss of 12 holders — while 88 trimmed existing stakes and 82 added.
The largest buyer was Goldman Sachs, adding an estimated $72.2M. The largest seller was Sachem Head Capital Management, exiting entirely with an estimated $104M sold.
- 254 institutional investors held Acadia Healthcare (ACHC) as of Q4 2025, down from 270 in Q3 2025.
- Funds reported $1.73B of Acadia Healthcare stock for Q4 2025, down 39% quarter-over-quarter.
- 60 funds opened new Acadia Healthcare positions in Q4 2025 and 72 closed out, a net change of -12 holders.
- The largest Acadia Healthcare buyer in Q4 2025 was Goldman Sachs, an estimated $72.2M added.
- The largest Acadia Healthcare seller in Q4 2025 was Sachem Head Capital Management, an estimated $104M sold.
Based on aggregated 13F filings for Q4 2025.